Showing results (271-280 of 358) with videos related to

Sort By:
Pageof 36
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 1999
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on DementiaC J Patterson, S Gauthier, H Bergman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 10, 2001
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on DementiaC Patterson, S Gauthier, H Bergman, et al.
Endocrinology|May 16, 1998
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouseC Martel, C Labrie, A Bélanger, et al.
Neuron|April 20, 2007
Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndromeAndrée S Gauthier, Olivia Furstoss, Toshiyuki Araki, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force ReportS Gauthier, A Boxer, D Knopman, et al.
Retina (Philadelphia, Pa.)|February 24, 2001
Methylprednisolone concentrations in the vitreous and the serum after pulse therapyF F Behar-Cohen, S Gauthier, A El Aouni, et al.
Life Sciences|December 16, 1985
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementiaB E Suranyi-Cadotte, S Gauthier, F Lafaille, et al.
International Psychogeriatrics|May 3, 2017
Suicide and assisted dying in dementia: what we know and what we need to know. A narrative literature reviewJ Diehl-Schmid, R Jox, S Gauthier, et al.
Neurobiology of Aging|May 1, 1989
Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer typeS Lal, N P Nair, J X Thavundayil, et al.
The New England Journal of Medicine|October 2, 1980
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopaE M Sternberg, M H Van Woert, S N Young, et al.
Pageof 36